Cargando…
A NR2E1‐interacting peptide of LSD1 inhibits the proliferation of brain tumour initiating cells
OBJECTIVES: Elimination of brain tumour initiating cells (BTICs) is important for the good prognosis of malignant brain tumour treatment. To develop a novel strategy targeting BTICs, we studied NR2E1(TLX) involved self‐renewal mechanism of BTICs and explored the intervention means. MATERIALS AND MET...
Autores principales: | Hu, Rong, Hameed, Umar Farook Shahul, Sun, Xiang, Moorthy, Balakrishnan Shenbaga, Zhang, Wen, Jeffrey, Philip D., Zhou, Li, Ma, Xin, Chen, Fangjin, Pei, Jianfeng, Giri, Pankaj K., Mou, Yonggao, Swaminathan, Kunchithapadam, Yuan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816925/ https://www.ncbi.nlm.nih.gov/pubmed/36321378 http://dx.doi.org/10.1111/cpr.13350 |
Ejemplares similares
-
Transcriptional Repressor Domain of MBD1 is Intrinsically Disordered and Interacts with its Binding Partners in a Selective Manner
por: Hameed, Umar Farook Shahul, et al.
Publicado: (2014) -
Modifying the Substrate Specificity of Carcinoscorpius rotundicauda Serine Protease Inhibitor Domain 1 to Target Thrombin
por: Giri, Pankaj Kumar, et al.
Publicado: (2010) -
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer
por: Khanal, Tilak, et al.
Publicado: (2017) -
Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential
por: Bao, Lei, et al.
Publicado: (2023) -
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update
por: Malagraba, Gianluca, et al.
Publicado: (2022)